drugset
drugset / Trial / NCT04263792

[18F]Fluoropropyl-Trimethoprim ([18F]F-TMP) PET/CT Imaging to Evaluate Biodistribution and Kinetics in Human Subjects

NCT04263792 ↗

Phase 1 Recruiting 20 enrolled University of Pennsylvania
Non-randomizedParallel-groupOpen-labelOther

Summary

The purpose of this study is to study a radioactive tracer, a type of imaging drug that is injected into the body to see how it is taken up in sites of active infection using an imaging procedure called Positron Emission Tomography/Computed Tomography (PET/CT).

Timeline

Start
2020-02-07
Primary completion
2026-07
Completion
2027-01

Drugs

EvaluationDrugModalityDoseRoute
Subject [18F]Fluoropropyl-Trimethoprim Diagnostic / imaging agent — Other

Indications

bacterial infectious disease